ProfileGDS5678 / 1453129_a_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 20% 30% 21% 23% 30% 20% 20% 22% 22% 38% 22% 22% 12% 37% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.5051520
GSM967853U87-EV human glioblastoma xenograft - Control 22.6770130
GSM967854U87-EV human glioblastoma xenograft - Control 32.4988221
GSM967855U87-EV human glioblastoma xenograft - Control 42.4789523
GSM967856U87-EV human glioblastoma xenograft - Control 52.6254330
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.5331120
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.508720
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.4962422
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.4931422
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.8469738
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.4965622
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.4984822
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.2822912
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.8309537